Addex Therapeutics Ltd. (ADXN)
3.18
+0.08
(+2.58%)
USD |
NASDAQ |
Oct 06, 16:00
2.97
-0.21
(-6.60%)
After-Hours: 20:00
Addex Therapeutics Net Income (Quarterly) : -2.207M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.207M |
| March 31, 2026 | -2.184M |
| December 31, 2025 | -2.294M |
| September 30, 2025 | -1.971M |
| June 30, 2025 | -2.369M |
| March 31, 2025 | -1.638M |
| December 31, 2024 | -1.356M |
| September 30, 2024 | -1.763M |
| June 30, 2024 | -1.611M |
| March 31, 2024 | -0.8408M |
| December 31, 2023 | -1.012M |
| September 30, 2023 | -0.8041M |
| June 30, 2023 | -0.5798M |
| March 31, 2023 | -0.3999M |
| December 31, 2022 | -3.788M |
| September 30, 2022 | -4.249M |
| Date | Value |
|---|---|
| June 30, 2022 | -7.481M |
| March 31, 2022 | -6.304M |
| December 31, 2021 | -4.799M |
| September 30, 2021 | -3.919M |
| June 30, 2021 | -5.152M |
| March 31, 2021 | -2.913M |
| December 31, 2020 | -2.351M |
| September 30, 2020 | -3.602M |
| June 30, 2020 | -3.233M |
| March 31, 2020 | -4.447M |
| December 31, 2007 | 0.00 |
| June 30, 2007 | -9.972M |
| March 31, 2007 | -5.970M |
| December 31, 2006 | |
| June 30, 2006 | -3.843M |
| March 31, 2006 | -3.748M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Novartis AG | 3.259B |
| Roche Holding AG | -- |
| Oculis Holding AG | -12.61M |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0126M |
| Total Expenses (Quarterly) | 2.22M |
| EPS Diluted (Quarterly) | -2.160 |
| Enterprise Value | 2.436M |
| Gross Profit Margin (Quarterly) | -153.2% |
| Profit Margin (Quarterly) | -17.52K% |
| Earnings Yield | -277.1% |
| Normalized Earnings Yield | -277.04 |